Laura has been working in the field of implementation of new non animal based assays in vaccines and biologicals since 2011, first in Novartis International, then in Novartis Vaccines and Diagnostics, GSK Biologicals and in the Developing Countries Vaccine Manufacturers Network. Since 2017, she works as consultant for many international organizations on the promotion of global regulatory alignment on implementation of non-animal approaches for human and veterinary biological products. In particular, she is supporting Humane Society International in non-animal methods implementation and acceptance. She is engaged in analyzing dynamics in how biomedical research is opening on new models and methods (organoids, in silico, etc.) and in general in supporting organizations in project creation and management.